Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The nucleoprotein (NP) of Taï Forest ebolavirus is a viral structural protein essential for the virus's life cycle. It oligomerizes to form a helical capsid, encapsidating the viral genome and protecting it. NP is crucial for the formation of the ribonucleoprotein complex (RNP), which is critical for viral RNA synthesis, replication, and assembly. The protein contains N-lobe and C-lobe domains that clamp around the RNA binding groove, and interactions with VP30 are crucial for transcription initiation. NP is considered a therapeutic target due to its essential role in viral replication and a valuable tool for immunological studies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Taï Forest ebolavirus nucleoprotein (NP).